RxDoctor Payments Data

Michael Karathanos

Neurology · Tulsa, OKNPI 1164416244

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Biogen. That places this record below the midpoint for neurology clinicians in OK, where the typical reported total is $1,439.

$134in general payments, 2019–2025

Across 1 payment — averaging $133.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$134
$4,382,924in research payments, 2019–2025

Across 193 payments — averaging $22,709 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2M
  • Eisai Inc.$2M
  • AbbVie$222K
  • Genentech, Inc.$157K
  • Boehringer Ingelheim$55K
  • Novartis$10K
  • plus $7K from 2 others

What the payments were for

  • Food & beverage$134100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen1$134

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134 in reported general payments places this provider in the 20th percentile of 152 neurology providers in Oklahoma.

See all neurology providers in Oklahoma

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$5,746

Paid to pharmacies, not to this prescriber.

Other neurology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →